Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell Carcinoma: a prospective evaluation

被引：0
|
作者：
M Staehler
N Haseke
A Roosen
T Stadler
M Bader
M Siebels
A Karl
CG Stief
机构：
[1] Klinikum Grosshadern,Department of Urology, University of Munich
来源：
European Journal of Medical Research | / 15卷
关键词：
renal cell carcinoma; sarcomatoid; chemotherapy; sorafenib; multi-kinase inhibitor; survival; angiogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Phase I Trial of Sorafenib Plus Gemcitabine and Capecitabine for Patients With Advanced Renal Cell Carcinoma New York Cancer Consortium Trial NCI 6981
    Tagawa, Scott T.
    Milowsky, Matthew I.
    Jeske, Stephanie
    Mazumdar, Madhu
    Kung, Sophia
    Sung, Max
    Lehrer, Deborah
    Matulich, Daniel
    Selzer, Jodi
    Wright, John J.
    Nanus, David M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (05): : 443 - 448
  • [42] Molecular correlates of activity and survival in a phase I/II trial of sorafenib plus gemcitabine and capecitabine for advanced renal cell carcinoma
    Faltas, Bishoy
    Kaur, Gurveen
    Akhtar, Naveed
    Christos, Paul
    Robinson, Brian
    Singh, Beerinder
    Beltran, Himisha
    Nanus, David
    Tagawa, Scott T.
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Sorafenib rechallenge in patients with metastatic renal cell carcinoma
    Nozawa, Masahiro
    Yamamoto, Yutaka
    Minami, Takafumi
    Shimizu, Nobutaka
    Hatanaka, Yuji
    Tsuji, Hidenori
    Uemura, Hirotsugu
    BJU INTERNATIONAL, 2012, 110 (6B) : E228 - E234
  • [44] Sorafenib and sunitinib for elderly patients with renal cell carcinoma
    Miled, Olfa Derbel
    Dionne, Christine
    Terret, Catherine
    Segura-Ferlay, Celine
    Flechon, Aude
    Neidhart, Eve-Marie
    Negrier, Sylvie
    Droz, Jean-Pierre
    JOURNAL OF GERIATRIC ONCOLOGY, 2013, 4 (03) : 255 - 261
  • [45] A novel prognostic model for patients with sarcomatoid renal cell carcinoma
    Zhang, Ben Y.
    Thompson, R. Houston
    Lohse, Christine M.
    Leibovich, Bradley C.
    Boorjian, Stephen A.
    Cheville, John C.
    Costello, Brian A.
    BJU INTERNATIONAL, 2015, 115 (03) : 405 - 411
  • [46] Where Does the Combination of Sorafenib and Interferon in Renal Cell Carcinoma Stand?
    Flaherty, Keith T.
    CANCER, 2010, 116 (01) : 4 - 7
  • [47] Comorbidity and sorafenib (SOR) therapy in elderly patients with metastatic renal cell carcinoma (mRCC)
    Gernone, A.
    Pagliarulo, A.
    Pagliarulo, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [48] A phase II trial of sunitinib and gemcitabine in sarcomatoid and/or poor-risk patients with metastatic renal cell carcinoma.
    McKay, Rana R.
    Choueiri, Toni K.
    Werner, Lillian
    Atkins, Michael B.
    Olivier, Kara M.
    Song, Jiaxi
    Signoretti, Sabina
    McDermott, David F.
    Michaelson, M. Dror
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [49] Long-term therapy with sunitinib and sorafenib in patients with metastasizing renal cell carcinoma
    Richter, S.
    Piper, C.
    Pfister, D. A.
    Brehmer, B.
    Heidenreich, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [50] Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma
    Mian, BM
    Bhadkamkar, N
    Slaton, JW
    Pisters, PWT
    Daliani, D
    Swanson, DA
    Pisters, LL
    JOURNAL OF UROLOGY, 2002, 167 (01): : 65 - 70
12345